logo
Plus   Neg
Share
Email

Zogenix Inc. (ZGNX) Leaped To A New High On Phase 3 Study Results

Zogenix Inc. (ZGNX) announced Thursday morning that its second Phase 3 study of ZX008 met the primary endpoint and all key secondary endpoints.

Zogenix gapped open sharply higher Thursday, but traded in a range for the majority of the session. The stock closed up by 9.60 at $55.90 on strong volume. Zogenix broke out of a 1-month trading range and set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT